We are a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. Our product candidates are being developed to block the production of specific proteins associated with the development of treatment resistance, which we believe will increase survival time and improve the quality of life for cancer patients.
Mailing is Vancouver-based company (British Columbia, Canada) with a phone number 6047363678. Our data show that the company is located at the address: 550-2660 Oak Street. The company has a web site: www.oncogenex.ca.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.